Rafeh Naqash, Assistant Professor at OU Health Stephenson Cancer Center and 2025 Yvonne ‘Mentorship’ Award Winner, shared a post on X about a recent article he and his colleagues co-authored published in Translational Lung Cancer Research:
“Nice summary here on the role of STK11/KRAS in early stage NSCLC from our group led by Alessio Cortellini on what you need to know from the TME standpoint”
Title: KRAS and STK11 co-mutations in resectable non-small cell lung cancer: enduring prognostic value and impaired immunotherapy response
Authors: Luisana Sisca, Priscilla Cascetta, Ayesha Aijaz, Chiara Catania, Francesco Facchinetti, Abdul Rafeh Naqash, Biagio Ricciuti, Alessio Cortellini.
You can read the Full Article on the Translational Lung Cancer Research.
More posts featuring Rafeh Naqash on OncoDaily.